Board Meetings for SMSPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| SMSPHARMA | SMS Pharmaceuticals Limited | 14 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 10 Nov 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on Saturday, the 10th November, 2018 at the Registered Officer of the Company, illter alia, to consider and approve the Unaudited Standalone financial results for the Quarter and half-year ended 30th September, 2018.Further please note that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and our Code for ��Regulation and Prohibition of Insider Trading�� Trading Window of the Company shall be remained closed for all the Directors / officers /Designated Employees / Promoters of the Company from 3rd November, 2018 to 12th November, 2018 (both days inclusive), Trading Window will be open from 13th November, 2018.Please take the same to your records. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 28 Jul 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 26 May 2018 | Financial Results | To consider and approve the financial results for the period ended March 31, 2018, To consider, recommend dividend, if any for the financial year 2017-18, appointment of Sri Sharvan Kudaravalli as Additional Director, to consider and approve standalone and consolidated annual audited financial statements for the financial year ended 31st March, 2018 | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 08 Feb 2018 | Results/Others | inter alia to consider and approve the unaudited standalone financial results for the Quarter ended December 31, 2017 along with Limited Review Report. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 13 Dec 2017 | Results | inter alia to consider and approve the unaudited standalone financial results for the quarter ended September 30, 2017 along with Limited Review Report. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 27 Sept 2017 | Meeting Updates | To consider the proposal for Joint Venture, for the purpose of Contract Research Organization (CRO) & Contract Manufacturing Organization (CMO), between the Company and Chemo S.A (Switzerland). | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 13 Sept 2017 | Results | To consider and approve the unaudited standalone financial results for the Quarter ended June 30, 2017. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 11 Aug 2017 | Meeting Updates | inter alia, to consider and approve the following: 1) To consider and approve the Draft Directors' Report for Financial Year 2016-17. 2) To fix date, time and venue to convene the Annual General Meeting. 3) To fix the date of Book Closure & approve the matters relating to ensuing Annual General Meeting . 4) To consider and approve the draft Notice of the Annual General Meeting. 5) Any other matter with the permission of the Chair. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 30 May 2017 | Results/Dividend | inter alia, for the following items. 1) to consider and approve the Unaudited Standalone Quarterly results for Quarter ended on March 31, 2017. 2) To consider and approve Standalone and Consolidated Annual Audited Financial Statements for the financial year ended on March 31, 2017. 3) To consider, recommend dividend, if any for the financial year 2016-2017. 4) To consider and approve the requests received for reclassification of promoters shareholding from promoter category to public category. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 11 Feb 2017 | Results/Others | Inter alia, to consider the following business: 1. To approve the Standalone Unaudited Financial Results for the quarter ended on December 31, 2016 along-with Limited Review Report. 2. To consider the proposal for further investment in VKT Pharma Pvt Ltd, an associate Company by way of subscription to the equity shares. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 05 Nov 2016 | Results | inter alia, to consider and approve the Standalone Unaudited Financial Results for the quarter ended on September 30, 2016 along-with Limited Review Report thereon. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 10 Aug 2016 | Results/Others | inter alia, to consider and approve the following: a) Draft Scheme of Demerger. b) Unaudited Standalone & Consolidated financial results for Quarter ended on June 30, 2016 c)To consider and approve the Draft Directors Report for Financial Year 2015-16 d) To fix Time, Date and Venue for convene the 28th Annual General Meeting. e) To consider and approve the draft Notice of the 28th Annual General Meeting. f) To fix the Record Date for ascertaining the no. of shareholders eligible for receiving the Annual Report. g) To fix the Book Closure date for ascertaining the number of shareholders eligible for receiving the Dividend. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 14 May 2016 | Results | inter alia, to consider and approve the Unaudited Standalone Quarterly results for Quarter ended on March 31, 2016 along-with Standalone and Consolidated Annual Audited Financial Statements for the financial year ended on March 31, 2016. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 30 Mar 2016 | Others | inter-alia, 1. To consider the Report of Independent Committee for checkout the feasibility of Demerger. 2. To consider the proposal of Corporate Guarantee to its associate companies. |